According to Entrada Therapeutics's latest financial reports the company's current earnings (TTM) are โน7.84 B. In 2023 the company made an earning of -โน0.27 B an increase over its 2022 earnings that were of -โน8.16 B.The earnings displayed on this page is the company's Pretax Income.